Delasa Aghamirzaie is a principal bioinformatics scientist at DELFI Diagnostics, developer of accessible blood-based AI tests that deliver a new way to enhance cancer detection. She’s been working on the intersection of artificial intelligence, data science and genomics in academia and industry for several years. She earned her Bachelor of Science and Master of Science in Computer Engineering from Tehran Polytechnic and a PhD in Bioinformatics from Virginia Tech.